The Association Between Vitamin D Deficiency and Systemic Lupus Erythematosus: A Review of Foundational Immunological and Clinical Evidence

Abstract

Introduction: Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease driven by a loss of immune tolerance. Prior to 2010, a paradigm shift was occurring in the understanding of Vitamin D, moving beyond its classical role in bone metabolism to recognise its function as a potent immunomodulator. This review synthesises the foundational literature published before 2010 that explored the relationship between Vitamin D status and the pathogenesis and activity of SLE.

Literature Review: A substantial body of basic science research from this era established the immunological rationale for a link. The Vitamin D receptor was identified on key immune cells, including T cells, B cells, and antigen-presenting cells. In-vitro studies demonstrated that the active form of Vitamin D could suppress pro-inflammatory T-cell responses, inhibit B-cell proliferation and antibody production, and promote regulatory immune pathways. This was complemented by a growing number of clinical observational studies that consistently reported a high prevalence of Vitamin D deficiency and insufficiency in SLE patient cohorts. Furthermore, early cross-sectional studies began to uncover an inverse correlation between serum Vitamin D levels and SLE disease activity scores, suggesting a clinically relevant relationship.

Conclusion: The pre-2010 immunological and clinical evidence provides a strong basis for an association between Vitamin D deficiency and SLE. Foundational research established Vitamin D as a key regulator of immune function, while clinical studies confirmed its widespread deficiency in lupus patients and suggested a link to disease severity. This body of work positioned Vitamin D status as a plausible modifiable environmental factor in SLE.